Latest Headlines

  1. MTD Micro Molding Makes Inc. 5000 List Of Fastest Growing Companies For 2nd Time

    MTD Micro Molding, a long-time leader and expert problem solver in micro-injection molding for the medical device industry, made the Inc. 5000 list of America’s fastest growing companies for the second time. MTD Micro Molding was ranked at position #4735 due to its three-year growth of 48%.

  2. Medtronic Announces Randomized Global Resolute Onyx DES One-Month Dual Antiplatelet Therapy Study

    Medtronic plc recently announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT) - the combination of aspirin and an anti-clotting medication - in patients implanted with the Resolute Onyx Drug-Eluting Stent (DES) during percutaneous coronary intervention (PCI).

  3. Renovis Surgical’s 3D-Printed Posterior Lumbar Interbody Fusion Systems Cleared By FDA

    Renovis Surgical Technologies, Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market posterior lumbar Tesera® porous titanium interbody fusion systems.

  4. Proto Labs Expands 3D Printing Service With HP’s Multi Jet Fusion Technology

    Proto Labs, a global leader in technology-enabled, rapid manufacturing, has announced the addition of Multi Jet Fusion to its suite of 3D printing technologies. The production-grade 3D printing technology, developed by HP, builds fully functional plastic prototypes and production parts with accelerated speed, detailed precision, and consistent mechanical properties.

  5. Fresenius To Acquire NxStage Medical, Bolstering Home Dialysis, Critical Care

    Fresenius Medical Care, the world’s largest provider of dialysis products and services, has signed an agreement to acquire NxStage Medical, Inc., (NxStage) a U.S.-based medical technology and services company

  6. GE’s SIGNA Premier 3.0 MRI Cleared By FDA

    GE Healthcare is proud to announce SIGNA Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available for sale in the U.S. SIGNA Premier is the result of a four-year collaboration with the National Football League (NFL) and research institutions around the world working to design new imaging tools, particularly to aid researchers in the detection of biomarkers for the potential diagnosis of mild Traumatic Brain Injury.

  7. Medtronic’s Avalus Surgical Aortic Valve Gains FDA, CE Mark Approval

    Medtronic plc recently announced CE (Conformité Européenne) mark and U.S. Food and Drug Administration (FDA) approval of its new Avalus pericardial aortic surgical valve for the treatment of aortic valve disease.

  8. Rapid 3D Printing In Water Using Novel Hybrid Nanoparticles Holds Promise For Old And New Industries

    Researchers at the Hebrew University of Jerusalem’s Center for Nanoscience and Nanotechnology have developed a new type of photoinitiator for three-dimensional (3D) printing in water.

  9. Immunalysis’ Fentanyl Urine Drug Screening Test Cleared By FDA

    Immunalysis Corporation, a division of Alere Inc. (NYSE: ALR), today announced that its SEFRIA™ Fentanyl Urine Enzyme Immunoassay has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for the qualitative detection of fentanyl in urine.

  10. Medtronic’s CoreValve Evolut PRO TAVR Gains CE Mark, Launches In EU

    Medtronic plc recently announced CE (Conformité Européenne) mark and European launch of the CoreValve Evolut PRO valve for the treatment of severe aortic stenosis for symptomatic patients who are at intermediate, high or extreme risk for open heart surgery